Open Access<p>Assessment of Renal Function in Post-Liver Transplant HCV-Positive Patients Treated with Direct Acting Antivirals</p>
Author(s) -
Khaled Mohamed Amin Elzorkany,
Mahmoud A Kora,
Aliaa Sabry Abdel Wahed,
Hassan Zaghla,
Ahmed Zahran,
Yassein Salah Yassein,
Asmaa Zaki El Naggar,
Abdallah Essa,
Abdelnaser Abdelaty Gadallah
Publication year - 2020
Publication title -
international journal of nephrology and renovascular disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.846
H-Index - 27
ISSN - 1178-7058
DOI - 10.2147/ijnrd.s275721
Subject(s) - medicine , daclatasvir , sofosbuvir , gastroenterology , renal function , liver function , regimen , ribavirin , hepatitis c virus , hepatitis c , pharmacology , immunology , virus
Direct acting antiviral agents (DAAs) have greatly improved the clearance of hepatitis C virus (HCV) infection. The effect of DAAs on renal function in post-liver transplant HCV-positive patients remains questionable, especially considering the possibility of drug interactions between immunosuppressants and DAAs.